Keybanc Maintains Overweight on Thermo Fisher Scientific, Lowers Price Target to $640
Portfolio Pulse from richadhand@benzinga.com
Keybanc analyst Paul Knight maintains an Overweight rating on Thermo Fisher Scientific (NYSE:TMO) but lowers the price target from $710 to $640.
May 25, 2023 | 8:18 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Keybanc analyst Paul Knight maintains an Overweight rating on Thermo Fisher Scientific (TMO) but lowers the price target from $710 to $640.
The news of Keybanc maintaining an Overweight rating on Thermo Fisher Scientific (TMO) is positive for the stock. However, the lowering of the price target from $710 to $640 may create some uncertainty among investors. The overall impact on the stock price in the short term is expected to be neutral.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100